CN1385206A - Zhongfengnaoxintong for treating apoplexy - Google Patents

Zhongfengnaoxintong for treating apoplexy Download PDF

Info

Publication number
CN1385206A
CN1385206A CN 02120830 CN02120830A CN1385206A CN 1385206 A CN1385206 A CN 1385206A CN 02120830 CN02120830 CN 02120830 CN 02120830 A CN02120830 A CN 02120830A CN 1385206 A CN1385206 A CN 1385206A
Authority
CN
China
Prior art keywords
radix
fructus
apoplexy
radix angelicae
agkistrodon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02120830
Other languages
Chinese (zh)
Inventor
王洪臣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 02120830 priority Critical patent/CN1385206A/en
Publication of CN1385206A publication Critical patent/CN1385206A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese patent medicine Zhongfengnaoxintong for curing apoplexy and its sequelae is made of 26 Chinese medicinal materials of scorpion, sargentodoxa stem, red peony root, ligusticum root, chaenomeles fruit, achyranthes root, earthworm and others through the processes of pulverizing, seiving and mixing. It can be used for curing hemiplegia and half-body paralysis.

Description

The apoplexy NAOXINTONG
The invention belongs to the oral patent medicine of the traditional Chinese medical science of treatment apoplexy and hemiplegia.
The apoplexy traditional Chinese medical science is called apoplexy, it is a kind of sudden illness of serious threat middle-aged and elderly people life and health, modern medicine proof apoplexy majority is by cerebral hemorrhage, cardiovascular and cerebrovascularinfarction causes, morbidity suddenly often, also in the treatment have a prognosis mala more, and many paralytics leave apoplexy sequela such as aphasis, handicapped, hemiplegia even general paralysis after rescuing, apoplexy disease people are pressed for effective in cure better prevention and medicine.
Content of the present invention is to select Scorpio, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Chaenomelis, Niu Xi, Pheretima, Rhizoma Drynariae, Radix Dipsaci, Radix Angelicae Sinensis, the Radix Astragali, Semen Persicae, eupolyphage sece steleophaga, Radix Salviae Miltiorrhizae, Myrrha, Bombyx Batryticatus, Flos Carthami, Ramulus Cinnamomi, Fructus Corni, Caulis Spatholobi, Herba Apocyni veneti, Borneolum Syntheticum, Fructus Lycii, baked polygonum capitatum, Carapax et Plastrum Testudinis, the Agkistrodon prescription compatibility of energy activating blood circulation to dissipate blood stasis, balancing blood pressure, adjustment heart rate, the awake key of thrombolytic for use, mixing sieves makes powder through pulverizing, promptly constitute apoplexy NAOXINTONG of the present invention, be used for prevention and treatment apoplexy and sequela thereof.
The invention will be further described with the specific embodiment below, select Scorpio 20g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 20g, Radix Paeoniae Rubra 30g, Rhizoma Chuanxiong 40g, Fructus Chaenomelis 40g, cattle sunset 40g, Pheretima 30g, Rhizoma Drynariae 40g, Radix Dipsaci 30g, Radix Angelicae Sinensis 40g, Radix Astragali 100g, Semen Persicae 30g, eupolyphage sece steleophaga 10g, Radix Salviae Miltiorrhizae 40g, Myrrha 30g, Bombyx Batryticatus 20g, Flos Carthami 50g, Ramulus Cinnamomi 40g, Fructus Corni 40g, Caulis Spatholobi 30g, Herba Apocyni veneti 40g, Borneolum Syntheticum 1g, Fructus Lycii 100g, baked polygonum capitatum 40g, Carapax et Plastrum Testudinis 30g, Agkistrodon 10g, Bombyx Batryticatus wherein, eupolyphage sece steleophaga, Agkistrodon, Pheretima, Carapax et Plastrum Testudinis is put into the roasting extremely clear-cut sustainability of little Huang of baking box so that pulverize, the independent porphyrize of Borneolum Syntheticum, all the other are pulverized jointly, 120 orders sieve after all mixing, meter makes powder 900 grams, each clothes 10 grams, every day, three warm yellow wine sent down, every month is a course of treatment, for conveniently take can be made into watered pill honeyed pill also can be encapsulated.

Claims (1)

1, the apoplexy NAOXINTONG belongs to prevention and the oral Chinese medicine for the treatment of apoplexy and sequela thereof, by Scorpio, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Radix Paeoniae Rubra, Rhizoma Chuanxiong, Fructus Chaenomelis, Niu Xi, Pheretima, Rhizoma Drynariae, Radix Dipsaci, Radix Angelicae Sinensis, the Radix Astragali, Semen Persicae, eupolyphage sece steleophaga, Radix Salviae Miltiorrhizae, Myrrha, Bombyx Batryticatus, Flos Carthami, Ramulus Cinnamomi, Fructus Corni, Caulis Spatholobi, Herba Apocyni veneti, Borneolum Syntheticum, Fructus Lycii, baked polygonum capitatum, Carapax et Plastrum Testudinis, Agkistrodon is mixed and made into through crushing screening, it is characterized in that the compatibility weight ratio is Scorpio 20g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 20g, Radix Paeoniae Rubra 30g, Rhizoma Chuanxiong 40g, Fructus Chaenomelis 40g, cattle sunset 40g, Pheretima 30g, Rhizoma Drynariae 40g, Radix Dipsaci 30g, Radix Angelicae Sinensis 40g, Radix Astragali 100g, Semen Persicae 30g, eupolyphage sece steleophaga 10g, Radix Salviae Miltiorrhizae 40g, Myrrha 30g, Bombyx Batryticatus 20g, Flos Carthami 50g, Ramulus Cinnamomi 40g, Fructus Corni 40g, Caulis Spatholobi 30g, Herba Apocyni veneti 40g, Borneolum Syntheticum 1g, Fructus Lycii 100g, baked polygonum capitatum 40g, Carapax et Plastrum Testudinis 30g, Agkistrodon 10g.
CN 02120830 2002-06-05 2002-06-05 Zhongfengnaoxintong for treating apoplexy Pending CN1385206A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02120830 CN1385206A (en) 2002-06-05 2002-06-05 Zhongfengnaoxintong for treating apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02120830 CN1385206A (en) 2002-06-05 2002-06-05 Zhongfengnaoxintong for treating apoplexy

Publications (1)

Publication Number Publication Date
CN1385206A true CN1385206A (en) 2002-12-18

Family

ID=4744817

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02120830 Pending CN1385206A (en) 2002-06-05 2002-06-05 Zhongfengnaoxintong for treating apoplexy

Country Status (1)

Country Link
CN (1) CN1385206A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283919A (en) * 2011-07-07 2011-12-21 黑龙江久久药业有限责任公司 Traditional Chinese medicine compound preparation for treating apoplexia and preparation method thereof
CN104013836A (en) * 2014-06-26 2014-09-03 王芬 Traditional Chinese medicine composition for treating sequela of cerebral apoplexy

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283919A (en) * 2011-07-07 2011-12-21 黑龙江久久药业有限责任公司 Traditional Chinese medicine compound preparation for treating apoplexia and preparation method thereof
CN104013836A (en) * 2014-06-26 2014-09-03 王芬 Traditional Chinese medicine composition for treating sequela of cerebral apoplexy
CN104013836B (en) * 2014-06-26 2016-11-23 河南中医学院 A kind of Chinese medicine composition treating cerebral apoplexy sequela

Similar Documents

Publication Publication Date Title
CN1115156C (en) Antisenility Chinese medicine
CN1485083A (en) Capsule for thyroid cancer / tumor and lymph node
CN1298370C (en) Kidney benefiting essence culturing pills
CN101357175B (en) Traditional Chinese medicine composition of foot soaking and massage
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN1347709A (en) Cardiac and cerebral vascular disease treating medicine
CN101884764A (en) Medicament for treating chronic hepatitis splenomegaly or cirrhosis splenomegaly
CN101244245A (en) Chinese medicine composition for blood circulation activating and stasis removing
CN1891279A (en) Capsule for treating cardio-cerebrovasular disease
CN103041285A (en) Cerebral apoplexy commemorative sign treatment method by utilizing Chinese medicaments
CN102423442B (en) Double-component medicine for treating fatty liver and preparation method thereof
CN101683430A (en) Traditional Chinese medicine composition for treating lacunar infarction
CN103599496A (en) Traditional Chinese medicine for treatment of chronic gastritis
CN105996024A (en) Nourishing nutrient combination for soup cooking and preparation method of combination
CN1159037C (en) Medicine for treating apoplexy
CN1218706C (en) Hepatitis B treaitng pill
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN1385206A (en) Zhongfengnaoxintong for treating apoplexy
CN1176695C (en) Gansukang capsule
CN101926880A (en) Chinese medicinal composition for treating amenorrhea and endometritis of women
CN102423441A (en) Double-formula medicine used for treating constipation, and preparation method thereof
CN1209142C (en) Rongshuan jiannaokang thrombolytic
CN101336976A (en) Oral traditional Chinese medicine formulation for treating genital herpes and preparation method thereof
CN101683446A (en) Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat
CN1371714A (en) Powder medicine for treating liver disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication